Ultivue: Funding, Investors & Team (Sep 2026)
Ultivue is a biotechnology firm focusing on tissue imaging, diagnostics, and multiplexing. They create reagents that allow researchers to capture high-resolution microscopic images, aiding in the study of biology and medicine. Ultivue's products are tailored for fluorescent microscopy research and may have future applications in clinical diagnostics. Established in 2015, Ultivue is based in Cambridge, Massachusetts.
Ultivue has raised $53.3M across 2 funding rounds on record, the most recent an undisclosed round of $3.3M announced in Jul 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ultivue Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Ultivue Funding Rounds
Ultivue raised $50.0M in a Series D announced in Apr 2021.
3.3 years later, an undisclosed round of $3.3M was announced in Jul 2024.
Ultivue Founders and Leadership Team
Contact details for the Ultivue team: 1 of 2 have an email address on file.
Start 14-day free trial →Ultivue Funding Compared to Other Biotechnology Startups
Ultivue's latest round of $3.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ultivue in Biotechnology and Cambridge
Companies Similar to Ultivue
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Ultivue Funding FAQs
What does Ultivue do?
Ultivue is a biotechnology firm focusing on tissue imaging, diagnostics, and multiplexing. They create reagents that allow researchers to capture high-resolution microscopic images, aiding in the study of biology and medicine. Ultivue's products are tailored for fluorescent microscopy research and may have future applications in clinical diagnostics. Established in 2015, Ultivue is based in Cambridge, Massachusetts.
How much funding has Ultivue raised?
Ultivue has raised $53.3M across 2 rounds on record. The most recent is an undisclosed round of $3.3M announced in Jul 2024.
When did Ultivue last raise funding?
Ultivue's most recent funding round on record is an undisclosed round of $3.3M, announced in Jul 2024.
Who founded Ultivue?
FundedIQ lists Ralf Jungmann (Founder) at Ultivue.
Who is the CEO of Ultivue?
Jacques Corriveau is listed as CEO at Ultivue.
Where is Ultivue headquartered?
Ultivue is based in Cambridge, Massachusetts, United States.
How many employees does Ultivue have?
Ultivue is in the 51-100 employee band.
How does Ultivue's funding compare to other Biotechnology startups?
Ultivue's latest round of $3.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Ultivue Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ultivue is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.